Kraig Biocraft Laboratories to Hold Shareholders' Meeting on April 16, 2013
April 03 2013 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the "Company"), the
leading developer of advanced spider silk based fibers, will hold a
shareholder meeting on April 16, 2013. Along with the notice of
meeting, the Company's founder and CEO, Kim K Thompson has posted a
letter to the shareholders on the Company's website.
"We plan to continue accelerating our commercial development
through 2013 and beyond," said CEO and founder Kim K
Thompson. "We will also be announcing a shareholder conference
call to be held sometime after the shareholders' meeting, to
discuss our progress and ambitious plans for 2013 and 2014."
To view the letter to shareholders as well as the notice of the
shareholder meeting along with details regarding the meeting please
go to www.KraigLabs.com. The letter to shareholders and the
notice of the shareholder meeting are also being provided to
shareholders through electronic communication, for those who have
previously opted for electronic communication or through the US
postal service.
Furthermore, the Company is inviting shareholders to join the
Kraig e-mail alert list, which will allow the Company to
communicate more effectively with its shareholder community. For
periodic updates, notices and important press releases, please
subscribe by sending an email containing the words "shareholder,
add me to the list" to Shareholder@KraigLabs.com
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024